AFP and hepatocellular carcinoma: In a hepatocellular carcinoma (HCC) mouse model, treatment with DCsEVs derived from alpha-fetoprotein (AFP)-expressing DCs elevated the numbers of INF-γ-expressing CD8 + T cells and decreased the secretion of IL-10 and TGF-β [65].